U.S. Diagnostics Firm GenMark Explores Sale Amid Interest
- GenMark is working with financial adviser on potential sale
- Company valued at $1.5 billion after shares soar Thursday
This article is for subscribers only.
GenMark Diagnostics Inc. is exploring a sale after the U.S. firm was approached by potential buyers, according to people familiar with the matter.
GenMark is working with a financial adviser as it fields interest from other medical diagnostics companies, the people said, asking not to be identified because the deliberations are private.